R. Campbell

发表

Species-Specific Urothelial Toxicity with an anti-HIV Non-Catalytic Site Integrase Inhibitor (NCINI) is Related to Unusual pH-Dependent Physicochemical Changes.

R. Roberts, Joy Y. Feng, Yili Xu, 2021, Toxicological sciences : an official journal of the Society of Toxicology.

Animal Models of Multiple Myeloma and Their Utility in Drug Discovery

J. Berenson, R. Campbell, 2008, Current protocols in pharmacology.

Ethanol Stimulation of HIV Infection of Oral Epithelial Cells

O. Yang, I. Chen, S. Pang, 2004, Journal of acquired immune deficiency syndromes.

Regulation of prostate-specific antigen expression by the junctional adhesion molecule A.

M. Kamata, Xinmin Yan, W. Shi, 2009, Urology.

Involvement of claudin-7 in HIV infection of CD4(-) cells

O. Yang, I. Chen, R. Chiu, 2005, Retrovirology.

Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth.

H. Lee, J. Said, B. Bonavida, 2007, Blood.

The potent histone deacetylase inhibitor vorinostat, in combination with melphalan, markedly enhances the anti-myeloma effects of chemotherapy in vitro and in vivo

B. Bonavida, Haiming Chen, J. Berenson, 2008 .

gp120-Independent HIV Infection of Cells Derived From the Female Reproductive Tract, Brain, and Colon

O. Yang, I. Chen, R. Chiu, 2006, Journal of acquired immune deficiency syndromes.

Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis

H. Lee, M. Li, B. Bonavida, 2006, Oncogene.

NF-κB in the pathogenesis and treatment of multiple myeloma

Zhi-wei Li, B. Bonavida, Haiming Chen, 2008, Current opinion in hematology.

Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid

J. Said, B. Bonavida, S. Baritaki, 2007, British journal of haematology.

LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma.

J. Said, B. Bonavida, Honghao Yang, 2006, International journal of oncology.

The Humanized Anti-CD40 Antibody SGN-40 Inhibits Tumor Growth in LAGκ-1A, a CD40+ Mouse Model of Human Multiple Myeloma.

J. Said, B. Bonavida, J. Drachman, 2006 .

Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis.

J. Said, B. Bonavida, T. Deuel, 2009, Blood.

Vorinostat enhances the antimyeloma effects of melphalan and bortezomib

Haiming Chen, J. Berenson, E. Sanchez, 2010, European journal of haematology.

Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status

B. Bonavida, Haiming Chen, J. Berenson, 2006, British journal of haematology.

Transdifferentiation of Monocytes into Endothelial Cells by Pleiotrophin.

H. Lee, J. Said, B. Bonavida, 2005 .

Arsenic Trioxide Shows Synergistic Anti-Myeloma Effects When Combined with Bortezomib and Melphalan In Vitro and Helps Overcome Resistance of Multiple Myeloma Cells to These Treatments in Vivo.

J. Said, B. Bonavida, Daocheng Zhu, 2004 .